The effect of the COVID-19 pandemic on severe asthma care in Europe - will care change for good?

Footnotes

This manuscript has recently been accepted for publication in the ERJ Open Research. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJOR online. Please open or download the PDF to view this article.

Jochen Rüdiger reports receiving payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from the Education of swiss Emergency physicians. Participation on a Data Safety Monitoring Board or Advisory Board for Boehringer Ingelheim. Member of the Board of the Swiss Society of Pneumology and President Thorax section of the Swiss Ultrasound Society. All disclosures made outside the submitted work.

Sabina Škrgat reports receiving honoraria for lectures and educational events, supported by GSK, Astra Zeneca, Sanofi, Chiesi, Pliva Teva and Medis. Participation on Advisory boards of GSK, Astra Zeneca, Chiesi and Sanofi. All disclosures made outside the submitted work.

Simon Doe reports receiving support for attending meetings and/or travel from GSK and Sanofi, outside the submitted work.

Simone van der Sar – van der Brugge reports receiving payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from AstraZeneca and GSK, Support received from ALK for attending meetings and/or travel. All disclosures made outside the submitted work.

Dr Steven J Smith is Supported by the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No. 831434 for Taxonomy, Targets, Treatment, and Remission. The JU receives support from the European Union's Horizon 2020 research and innovation program and the European Federation of Pharmaceutical Industries and Associates. All disclosures made outside the submitted work.

Zsuzsanna Csoma reports receiving honoraria for presentations: Astra/Zeneca, TEVA, Sanofi/Aventis (Hungary), outside the submitted work.

Apostolos Bossios reports receiving payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from AZ, GSK, TEVA. Support for attending meetings and/or travel received from NOVARTIS. Participation on a Data Safety Monitoring Board or Advisory Board for AZ, GSK, NOVARTIS, TEVA, SANOFI. Member of the steering Committee of SHARP, Secretary of Assembly 5 (Airway diseases, asthma, COPD and chronic cough), European Respiratory Society; vice-chair of Nordic Severe Asthma Network (NSAN). All disclosures made outside the submitted work.

Arnaud Bourdin reports receiving grants or contracts outside the submitted work from Astra Zeneca and Boeringher Ingelheim. Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events as well as support for attending meetings and/or travel from Astra Zeneca, Boeringher Ingelheim, GSK, Novartis, Chiesi and Amgen, outside the submitted work.

Arne Egesten reports receiving honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from AstraZeneca, outside the submitted work.

David Aronsson reports receiving grants or contracts from ALK-Abello, outside the submitted work.

Elisabeth H. Bel reports support for the present manuscript from ERS. Grants or contracts received from GlaxoSmithKline and Teva, outside the submitted work. Consulting fees received from AstraZeneca, GlaxoSmithKline, Sanofi, Sterna and Chiesi, outside the submitted work. Honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events received from Teva. Participation on a Data Safety Monitoring Board or Advisory Board for AstraZeneca, outside the submitted work. Leadership or fiduciary role in other board, society, committee or advocacy group, unpaid for SHARP-CRC and RAPSODI (Dutch registry), outside the submitted work.

Enrico Heffler reports receiving payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from AstraZeneca; Sanofi-Genzyme; Regeneron; Novartis; GSK; Circassia; Stallergenes-Greer; Nestlè Purina, outside the submitted work.

Florian Charbonnier reports receiving payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Sanofi, Novartis, Mundipharma, AstraZeneca, and GSK. Participation on a Data Safety Monitoring Board or Advisory Board for Sanofi, Novartis, Mundipharma, AstraZeneca, and GSK. All disclosures made outside the submitted work.

Giorgio Walter CANONICA reports receiving consulting fees from AstraZeneca GSK, Novartis, Sanofi, and Stallergenes Greer. Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from AstraZeneca, GSK, Novartis, Sanofi, Stallergenes Greer, Menarini, Chiesi, and Mylan. Participation on a Data Safety Monitoring Board or Advisory Board for AstraZeneca, GSK, Novartis, Sanofi, Stallergenes Greer, and Chiesi. All disclosures made outside the submitted work.

Gert-Jan Braunstahl reports grants or contracts from GSK, AstraZeneca, and ALK Abello. Consulting fees from GSK, Sanofi, ALK Abello, AstraZeneca, and Novartis. Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from GSK, Sanofi, ALK Abello, AstraZeneca, and Novartis. Leadership or fiduciary role in other board, society, committee or advocacy group, paid or unpaid: Scientific board Dutch Lung Foundation, Task force Asthma NVALT, editorial board NTVAAKI. All disclosures made outside the submitted work.

Pietro Gianella reports participation on Advisory board Novartis about Xolair for Nasal polyps, outside the submitted work.

Lars Ahlbeck reports receiving payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from AstraZeneca. Participation on a Data Safety Monitoring Board or Advisory Board for AstraZeneca, Sanofi, and GSK. All disclosures made outside the submitted work.

Liam Heaney reports grants or contracts from Medimmune, Novartis UK, Roche/Genentech Inc, and Glaxo Smith Kline, Amgen, Genentech / Hoffman la Roche, Astra Zeneca, Medimmune, Glaxo Smith Kline, Aerocrine and Vitalograph. Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events for Novartis, Hoffman la Roche/Genentech Inc, Sanofi, Glaxo Smith Kline, Astra Zeneca, Teva and Circassia. Support for attending meetings and/or travel from AstraZeneca, Boehringer Ingelheim, Chiesi, GSK and Napp Pharmaceuticals. Participation on a Data Safety Monitoring Board or Advisory Board for Novartis, Hoffman la Roche/Genentech Inc, Sanofi, Evelo Biosciences, Glaxo Smith Kline, AstraZeneca, Teva, Theravance, and Circassia. All disclosures made outside the submitted work.

Matthew Masoli reports receiving grants or contracts from ERS SHARP to support the study ‘The burden of severe asthma on HRQoL across Europe’, outside the submitted work.

Michael Hyland reports receiving grants or contracts from TEVA. Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events for GSK. All disclosures made outside the submitted work.

Natalia Nenasheva reports receiving payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from AstraZeneca plc., Sanofi S.A., Teva Pharmaceuticals, Novartis International AG, and Chiesi Farmaceutici S.p.A., outside the submitted work.

Natalija Edelbaher reports receiving payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from GSK, Astra Zeneca, Chiesi, Pliva Teva, Krka, Novartis, Boehringer Ingelheim, and Sanofi. The author reports participation on Advisory boards of GSK, Astra Zeneca, Chiesi, Novartis, and Boehringer Ingelheim. All disclosures made outside the submitted work.

Nikolay Pavlov reports receiving payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from GSK, Novartis, and OM Pharma. Support for attending meetings and/or travel received from Boehringer Ingelheim. Participation on a Data Safety Monitoring Board or Advisory Board for AstraZeneca, GSK, Novartis, and Sanofi. All disclosures made outside the submitted work.

Peter Howarth reports to be employed by GSK.

Ratko Djukanovic reports support for the present manuscript received from ERS, TEVA, GSK, Novartis, Sanofi, and Chiesi. Consulting fees from Synairgen for which the author is a co-founder and consultant and owns shares, outside the submitted work. Participation on a Data Safety Monitoring Board or Advisory Board for Kymab (Cambridge), outside the submitted work.

Rekha Chaudhuri reports receiving grants or contracts from AstraZeneca. Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events for GSK, AstraZeneca, Teva, Chiesi, Sanofi, and Novartis. Support for attending meetings and/or travel received from Chiesi, Napp, Sanofi, Boehringer, GSK, and AZ. Participation on a Data Safety Monitoring Board or Advisory Board for GSK, AstraZeneca, Teva, Chiesi, and Novartis. All disclosures made outside the submitted work.

The remaining authors have nothing to disclose.